Selenium: an element for life

Endocrine

Volumn 48, Issue 3, 2015, Pages 756-775

  Duntas, Leonidas H ^a   Benvenga, Salvatore ^b,c  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

Author keywords

Autoimmunity; Selenium; Selenomethionine; Selenoproteins; Sodium selenite; Thyroid; Type 2 diabetes mellitus; Virology

Indexed keywords

SELENIUM;

HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; METABOLISM; PHYSIOLOGY; THYROID GLAND;

HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; SELENIUM; THYROID GLAND;

EID: 84938894262     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0477-6     Document Type: Review

References (181)

1. J.J. Berzelius, Lettre de M. Berzelius à M. Berthollet sur deux nouveaux métaux (Letter from Mr. Berzelius to Mr. Berthollet on two new metals). Annales Chimie et Physique 187, 199–200 (1817)
2. W. von Gümbel, M. von Reichenstein, F.J. Freiherr, Allgemeine Deutsche Biographie (ADB) (in German) 22, Leipzig: Duncker & Humblot 702–703 (1885)
3. R. Meyer, Martin Heinrich Klaproth, ein deutscher Chemiker des 18. Jahrhunderts. Zeitschrift für Angewandte Chemie 34, 1–3 (1921)
4. K. Schwarz, C.M. Foltz, Selenium as an integral part of factor 3 against dietary necrotic liver degeneration. J. Am. Chem. Soc. 79, 3292–3293 (1957)
5. K.M. Brown, R. Arthur, Selenium, selenoproteins and human health: a review. Public Health Nutr. 4, 593–599 (2001)
6. M.P. Rayman, Selenoproteins and human health: insights from epidemiological data. Biochim. Biophys. Acta 11, 1533–1540 (2009). doi:10.1016/j.bbagen.2009.03.014
7. C.D. Thomson, M.F. Robinson, Selenium in human health and disease with emphasis on those aspects peculiar to New Zealand. Am. J. Clin. Nutr. 33, 303–323 (1980)
8. C.D. Thomson, M.F. Robinson, Selenium content of foods consumed in Otago, New Zealand. N Z Med. J. 103(886), 130–135 (1990)
9. N.D. Grace, S.O. Knowles, Trace element supplementation of livestock in new zealand: meeting the challenges of free-range grazing systems. Vet. Med. Int. 2012, 639472–639479 (2012). doi:10.1155/2012/639472
10. W. Wasowicz, J. Gromadzinska, K. Rydzynski, J. Tomczak, Selenium status of low-selenium area residents: polish experience. Toxicol. Lett. 137, 95–101 (2003)
11. F. Gondi, G. Pantó, J. Fehér, G. Bogye, G. Alfthan, Selenium in Hungary. The rock-soil-human system. Biol. Trace Elem. Res. 35, 299–306 (1992)
12. G.F. Jr, Combs, Selenium in global food systems. Br. J. Nutr. 85, 517–547 (2001)
13. C. Thiry, A. Ruttens, L. Pussemier, Y.J. Schneider, An in vitro investigation of species-dependent intestinal transport of selenium and the impact of this process on selenium bioavailability. Br. J. Nutr. 109, 2126–2134 (2013). doi:10.1017/S0007114512004412
14. C.M. Weekley, H.H. Harris, Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease. Chem. Soc. Rev. 42, 8870–8894 (2013)
15. M.P. Rayman, H.G. Infante, M. Sargent, Food-chain selenium and human health: spotlight on speciation. Br. J. Nutr. 100, 238–253 (2008). doi:10.1017/S0007114508922522
16. Y. Kobayashi, Y. Ogra, K. Ishiwata, H. Takayama, N. Aimi, K.T. Suzuki, Selenosugars are key and urinary metabolites for selenium excretion within the required to low-toxic range. Proc. Natl. Acad. Sci. USA. 99, 15932–15936 (2002)
17. N. Waegeneers, C. Thiry, L. De Temmerman, A. Ruttens, Predicted dietary intake of selenium by the general adult population in Belgium. Food Addit. Contam. Part A. Chem. Anal. Control Expo. Risk Assess. 30, 278–285 doi:10.1080/19440049.2012.746474 (2013)
18. K. Park, E. Rimm, D. Siscovick, D. Spiegelman, J.S. Morris, D. Mozaffarian, Demographic and lifestyle factors and selenium levels in men and women in the U.S. Nutr. Res. Pract. 5, 357–364 (2011). doi: 10.4162/nrp.2011.5.4.357
19. M. Spadoni, M. Voltaggio, M. Carcea, E. Coni, A. Raggi, F. Cubadda, Bioaccessible selenium in Italian agricultural soils: comparison of the biogeochemical approach with a regression model based on geochemical and pedoclimatic variables. Sci. Total Environ. 376, 160–177 (2007)
20. J.W. Finley, Bioavailability of selenium from foods. Nutr. Rev. 64, 146–151 (2006)
21. J.M. Finley, M.A. Grusak, A.S. Keck, B.R. Gregoire, Bioavailability of selenium from meat and broccoli as determined by retention and distribution of 75Se. Biol. Trace Elem. Res. 99, 191–209 (2004)
22. A. Haug, R.D. Graham, O.A. Christophersen, G.H. Lyons, How to use the world’s scarce selenium resources efficiently to increase the selenium concentration in food. Microb Ecol Health Dis. 19, 209–228 (2007)
23. Keshan Disease Research Group, Epidemiological studies on the etiologic relationship of selenium in Keshan disease. Chin. Med. J. 92, 471–476 (1979)
24. Q. Li, M. Liu, J. Hou, C. Jiang, S. Li, T. Wang, The prevalence of Keshan disease in China. Int. J. Cardiol. 168, 1121–1126 (2013). doi:10.1016/j.ijcard.2012.11.046
25. B. Contempre, G. Morreale de Escobar, J.F. Denef, J.E. Dumont, M.C. Many, Thiocyanate induces cell necrosis and fibrosis in selenium- and iodine-deficient rat thyroids: a potential experimental model for myxedematous endemic cretinism in central Africa. Endocrinology 145, 994–1002 (2004)
26. J.E. Dumont, B. Corvilain, B. Contempre, The biochemistry of endemic cretinism: roles of iodine and selenium deficiency and goitrogens. Mol. Cell. Endocrinol. 100, 163–166 (1994)
27. G. Yang, L. Zhu, S. Liu, Human selenium requirements in China, in Selenium in biology and medicine, eds. by G.F. Combs, J.E. Spallholz, O.A. Levander, J.E. Oldfield (eds.) (Nostrand Rheinhold/AVI, New York, 1987) pp.589–607
28. M.F. Robinson, The New Zealand selenium experience. Am. J. Clin. Nutr. 48, 521–534 (1989)
29. J.T. Salonen, G. Alfthan, J.K. Huttunen, J. Pikkarainen, P. Puska, Association between cardiovascular death and myocardial infarction and serum selenium in a matched pair longitudinal study. Lancet 2, 175–179 (1982)
30. J. Virtamo, E. Valkeila, G. Alfthan, S. Punsar, J.K. Huttunen, M.J. Karvonen, Serum selenium and the risk of coronary heart disease and stroke. Am. J. Epidemiol. 122, 276–282 (1985)
31. B. Lloyd, R.S. Loyd, B.E. Clayton, Effect of smoking, alcohol, and other factors on the selenium status of a healthy population. J. Epidemiol. Commun. Health 37, 213–217 (1983)
32. Commission of the European Communities, Nutrient and energy intakes for the European Community. Reports of the Scientific Committee for Food, thirty first series, Office for Official Publications of the European Communities, Luxembourg (1993)
33. Italian Society of Human Nutrition, Document Revision 2012 RDAs (Reference Levels of Nutrients intake and energy for the Italian population) of the Italian Society of Human Nutrition (XXXV Congress SINU, Bologna 22–23 October 2012)
34. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. (National Academy Press, Washington, DC, 2000), pp 284–324
35. M. Mihajlovic, Selenium toxicity in domestic animals. Glas. Srp. Akad. Nauka. Med. 42, 131–144 (1992)
36. S. Shao, B. Zheng, The biogeochemistry of selenium in Sunan grassland, Gansu, Northwest China, casts doubt on the belief that Marco Polo reported selenosis for the first time in history. Environ. Geochem. Health 30, 307–314 (2008)
37. J.S. Morris, S.B. Crane, Selenium toxicity from a misformulated dietary supplement, adverse health effects, and the temporal response in the nail biologic monitor. Nutrients 5, 1024–1057 (2013)
38. K. Helzslouer, R. Jacobs, S. Morris, Acute selenium intoxication in the United States. Fed. Proc. 44, 1670 (1985)
39. J.K. McFarquhar, D.L. Broussard, P. Melstrom, R. Hutchinson, A. Wolkin, C. Martin, R.F. Burk, J.R. Dunn, A.L. Green, R. Hammond, W. Schaffner, T.F. Jones, Acute selenium toxicity associated with a dietary supplement. Arch. Int. Med. 170, 256–261 (2010)
40. B.M. Aldosary, M.E. Sutter, M. Schwartz, B.M. Morgan, Case series of selenium toxicity from a nutritional supplement. Clin. Toxicol. (Philadelphia, Pa.) 50, 57–64 (2012)
41. G. Yang, S. Wang, R. Zhou, S. Sun, Endemic selenium intoxication of humans in China. Am. J. Clin. Nutr. 37, 872–881 (1983)
42. G. Yang, S. Yin, L. Zhou, Studies of safe maximal dietary Se intake in a seleniferous area in China. Part II. Relation between Se intake and the manifestation of clinical signs and certain biochemical alterations in blood and urine. J. Trace Elem. Electrol. Health Dis. 3, 123–130 (1989)
43. S. Huang, M. Hua, J. Feng, X. Zhong, Y. Jin, B. Zhu, H. Lu, Assessment of selenium pollution in agricultural soils in the Xuzhou District, Northwest Jiangsu, China. J. Environ. Sci. (China) 21, 481–487 (2009)
44. M.E. Reid, M.S. Stratton, A.J. Lillico, M. Fakih, R. Natarajan, L.C. Clark, J.R. Marshall, A report of high-dose selenium supplementation: response and toxicities. J. Trace Elem. Med Biol. 18, 69–74 (2004)
45. M. Vinceti, G. Dennert, C.M. Crespi, M. Zwahlen, M. Brinkman, M.P. Zeegers, M. Horneber, R. D’Amico, C. Del Giovane C. Selenium for preventing cancer. Cochrane Database Syst Rev. 30;3:CD005195 (2014). doi:10.1002/14651858.CD005195.pub3
46. M. Vinceti, F. Bonvicini, K.J. Rothman, L. Vescovi, F. Wang, The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a population-based case-control study. Environ. Health. 9, 77 (2010). doi:10.1186/1476-069X-9-77
47. M. Ben-Porath, L. Case, E. Kaplan. The biological half-life of 75Se selenomethionine in man. J. Nucl. Med. 9, 168–169 (l968)
48. C.A. Swanson, B.H. Patterson, O.A. Levander, C. Veillon, P.R. Taylor, K. Helzlsouer, P.A. McAdam, L.A. Zech, Human [74Se] selenomethionine metabolism: a kinetic model. Am. J. Clin. Nutr. 54, 917–926 (1991)
49. B.H. Patterson, O.A. Levander, K. Helzlsouer, P.A. McAdam, S.A. Lewis, P.R. Taylor, C. Veillon, L.A. Zech, Human selenite metabolism: a kinetic model. Am. J. Physiol. 257, R556–R567 (1989)
50. C.D. Thomson, C.E. Burton, M.F. Robinson, On supplementing the selenium intake of New Zealanders. I. Short experiments with large doses of selenite or selenomethionine. Br. J. Nutr. 39, 579–587 (1978)
51. M.F. Robinson, H.M. Rca, G.M. Friend, R.D.H. Stewart, P.C. Snow, C.D. Thomson, On supplementing the selenium intake of New Zealanders. 2. Prolonged metabolic experiments with daily supplements of selenomethionine, selenite and fish. Br. J. Nutr. 39, 589–600 (1978)
52. M.E. Wastney, G.F. Combs Jr, W.K. Canfield, P.R. Taylor, K.Y. Patterson, A.D. Hill, J.E. Moler, B.H. Patterson, A human model of selenium that integrates metabolism from selenite and selenomethionine. J. Nutr. 141, 708–717 (2011). doi:10.3945/jn.110.129049
53. B. Gammelgaard, L.H. Rasmussen, C. Gabel-Jensen, B. Steffansen, Estimating intestinal absorption of inorganic and organic selenium compounds by in vitro flux and biotransformation studies in Caco-2 cells and ICP-MS detection. Biol. Trace Elem. Res. 145, 248–256 (2012). doi:10.1007/s12011-011-9174-y
54. M.J. Berry, L. Banu, Y.Y. Chen, S.J. Mandel, J.D. Kieffer, J.W. Harney, P.R. Larsen, Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353, 273–276 (1991)
55. M.T. Howard, B.A. Carlson, C.B. Anderson, D.L. Hatfield, Translational redefinition of UGA codons is regulated by selenium availability. J. Biol. Chem. 288, 19401–19413 (2013). doi:10.1074/jbc.M113.481051
56. M.J. Berry, L. Banu, J.W. Harney, P.R. Larsen, Functional characterization of the eukaryotic SECIS elements which direct selenocysteine insertion at UGA codons. EMBO J. 12, 3315–3322 (1993)
57. J. Köhrle, F. Jakob, B. Contempré, J.E. Dumont, Selenium, the thyroid and the endocrine system. Endocr. Rev. 26, 944–984 (2005)
58. M.J. Berry, L. Banu, P.R. Larsen, Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349, 438–440 (1991)
59. A.C. Bianco, D. Salvatore, B. Gereben, M.J. Berry, P.R. Larsen, Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr. Rev. 23, 38–89 (2002)
60. U. Schweizer, F. Streckfuss, P. Pelt, B.A. Carlson, D.L. Hartfeld, J. Koehrle, L. Schomburg, Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem. J. 386, 221–226 (2005)
61. K.E. Hill, S. Wu, A.K. Motley, T.D. Stevenson, V.P. Winfrey, M.R. Capecchi, J.F. Atkins, R.F. Burk, Production of selenoprotein P (Sepp1) by hepatocytes is central to selenium homeostasis. J. Biol. Chem. 287, 40414–40424 (2012). doi:10.1074/jbc.M112.421404
62. K. Renko, M. Werner, I. Renner-Müller, T.G. Cooper, C.H. Yeung, B. Hollenbach, M. Scharpf, J. Köhrle, L. Schomburg, U. Schweizer, Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice. Biochem. J. 409, 741–749 (2008)
63. K.E. Hill, J. Zhou, W.J. McMahan, A.K. Motley, R.F. Burk, Neurological dysfunction occurs in mice with targeted deletion of the selenoprotein P gene. J. Nutr. 134, 157–161 (2004)
64. J. Mittag, T. Behrends, C.S. Hoefig, B. Vennström, L. Schomburg, Thyroid hormones regulate selenoprotein expression and selenium status in mice. PLoS One 5, e12931 (2010)
65. N. Karunasinghe, D.Y. Han, S. Zhu, J. Yu, K. Lange, H. Duan, R. Medhora, N. Singh, J. Kan, W. Alzaher, B. Chen, S. Ko, C.M. Triggs, L.R. Ferguson, Serum selenium and single-nucleotide polymorphisms in genes for selenoproteins: relationship to markers of oxidative stress in men from Auckland, New Zealand. Genes Nutr. 7, 179–190 (2012)
66. C. Méplan, L.K. Crosley, F. Nicol, G.J. Beckett, A.F. Howie, K.E. Hill, G. Horgan, J.C. Mathers, J.R. Arthur, J.E. Hesketh, Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study). FASEB J. 21, 3063–3074 (2007)
67. N. Karunasinghe, D.Y. Han, S. Zhu, H. Duan, Y.J. Ko, J.F. Yu, C.M. Triggs, L.R. Ferguson, Effects of supplementation with selenium, as selenized yeast, in a healthy male population from New Zealand. Nutr. Cancer 65, 355–366 (2013). doi:10.1080/01635581.2013.760743
68. J. Aaseth, H. Frey, E. Glattre, G. Norheim, J. Ringstad, Y. Thomassen, Selenium concentration in the human thyroid gland. Biol. Trace Elem. Res. 24, 147–152 (1990)
69. B. Tiran, E. Karpf, A. Tiran, Age dependency of selenium and cadmium content in human liver, kidney, and thyroid. Arch. Environ. Health 50, 242–246 (1995)
70. J. Koehrle, The trace element selenium and the thyroid gland. Biochimie 81, 527–533 (1999)
71. G.J. Beckett, J.R. Arthur, Selenium and endocrine systems. J. Endocrinol. 184, 455–465 (2005)
72. L. Flohé, K.-D. Aumann, P. Steinert P. Role of selenium in the enzymatic reduction of hydroperoxides. Phosphorus Orous Sulfur Silicon. 136-138, 25–42 (1998)
73. L. Tan, Z.N. Sang, J. Shen, Y.T. Wu, Z.X. Yao, J.X. Zhang, N. Zhao, W.Q. Zhang, Selenium supplementation alleviates autoimmune thyroiditis by regulating expression of TH1/TH2 cytokines. Biomed. Environ. Sci. 26, 920–925 (2013). doi:10.3967/bes2013.022
74. J. Köhrle, R. Gärtner, Selenium and thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 23(6), 815–827 (2009). doi:10.1016/j.beem.2009.08.002
75. G.J. Beckett, S.E. Beddows, P.C. Morrice, F. Nicol, J.R. Arthur, Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. Biochem. J. 248, 443–447 (2003)
76. J. Chiu-Ugalde, E.K. Wirth, M.O. Klein, R. Sapin, N. Fradejas-Villar, K. Renko, L. Schomburg, J. Köhrle, U. Schweizer, Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid. Redox Signal. 17, 902–913 (2012). doi:10.1089/ars.2011.4055
77. S.J. Tsai, U. Sen, L. Zhao, W.B. Greenleaf, J. Dasgupta, E. Fiorillo, V. Orrú, N. Bottini, X.S. Chen, Crystal structure of the human lymphoid tyrosine phosphatase catalytic domain: insights into redox regulation. Biochem. 48, 4838–4845 (2009)
78. B. Contempré, J.E. Dumont, N. Bebe, C.H. Thilly, A.T. Diplock, J. Vanderpas, Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. J. Clin. Endocrinol. Metab. 73, 213–215 (1991)
79. B. Contempré, O. Le Moine, J.E. Dumont, J.F. Denef, M.C. Many, Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor beta (TGF-beta). Mol. Cell. Endocrinol. 124, 7–15 (1996)
80. J.B. Vanderpas, B. Contempré, N.L. Duale, H. Deckx, N. Bebe, A.O. Longombé, C.H. Thilly, A.T. Diplock, J.E. Dumont, Selenium deficiency mitigates hypothyroxinemia in iodine-deficient subjects. Am. J. Clin. Nutr. 57, 271S–275S (1993)
81. G. Karanikas, M. Schuetz, S. Kontur, H. Duan, S. Kommata, R. Schoen, A. Antoni, K. Kletter, R. Dudczak, M. Willheim, No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid. 18, 7–12 (2008)
82. W. Bonfig, R. Gärtner, H. Schmidt, Selenium supplementation does not decrease thyroid peroxidase antibody concentration in children and adolescents with autoimmune thyroiditis. Sci. World J. 10, 990–996 (2010)
83. S.A. Eskes, E. Endert, E. Fliers, E. Birnie, B. Hollenbach, L. Schomburg, J. Köhrle, W.M. Wiersinga, Selenite supplementation in euthyroids subjects with thyroid peroxidase antibodies. Clin. Endocrinol. (Oxf) (2013). doi:10.1111/cen.12284
84. R. Gärtner, B.C. Gasnier, J.W. Dietrich, B. Krebs, M.W. Angstwurm, Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J. Clin. Endocrinol. Metab. 87, 1687–1691 (2002)
85. R. Gärtner, B.C. Gasnier, Selenium in the treatment of autoimmune thyroiditis. BioFactors 19, 165–170 (2003)
86. D. Nacamulli, C. Mian, D. Petricca, F. Lazzarotto, S. Barollo, D. Pozza, S. Masiero, D. Faggian, M. Plebani, M.E. Girelli, F. Mantero, C. Betterle, Influence of physiological dietary selenium supplementation on the natural course of autoimmune thyroiditis. Clin. Endocrinol. (Oxf) 73, 535–539 (2010)
87. R. Negro, G. Greco, T. Mangieri, A. Pezzarossa, D. Dazzi, H. Hassan, The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J. Clin. Endocrinol. Metab. 92, 1263–1268 (2007)
88. L.H. Duntas, E. Mantzou, D.A. Koutras, Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur. J. Endocrinol. 148, 389–393 (2003)
89. E.E. Mazokopakis, J.A. Papadakis, M.G. Papadomanolaki, A.G. Batistakis, T.G. Giannakopoulos, E.E. Protopapadakis, E.S. Ganotakis, Effects of 12 months treatment with L-selenomethionine on serum anti-TPO levels in patients with Hashimoto’s thyroiditis. Thyroid. 17, 609–612 (2007)
90. O. Turker, K. Kumanlioglu, I. Karapolat, I. Dogan, The Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J. Endocrinol. 190, 151–156 (2006)
91. C. Balázs, The effect of selenium therapy on autoimmune thyroiditis. Orv. Hetil. 149, 1227–1232 (2008)
92. L. Zhu, X. Bai, W.P. Teng, Z.Y. Shan, W.W. Wang, C.L. Fan, H. Wang, H.M. Zhang, Effects of selenium supplementation on antibodies of autoimmune thyroiditis. Zhonghua Yi Xue Za Zhi 92, 2256–2260 (2012)
93. K.A. Toulis, A.D. Anastasilakis, T.G. Tzellos, D.G. Goulis, D. Kouvelas, Selenium supplementation in the treatment of Hashimoto’s thyroiditis: a systematic review and a meta-analysis. Thyroid 20, 1163–1173 (2010)
94. E.J. van Zuuren, A.Y. Albusta, Z. Fedorowicz, B. Carter, H. Pijl, Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst. Rev. 6, CD01:0223 (2013)
95. L.H. Duntas, Selenium and the thyroid: a close-knit connection. J. Clin. Endocrinol. Metab. 95, 5180–5188 (2010)
96. D. Nacamulli, D. Petricca, C. Mian, Selenium and autoimmune thyroiditis. J. Endocrinol. Invest. 36(10 Suppl), 8–14 (2013)
97. J.E. Curran, J.B. Jowett, K.S. Elliott, Y. Gao, K. Gluschenko, J. Wang, D.M. Abel Azim, G. Cai, M.C. Mahaney, A.G. Comuzzie, T.D. Dyer, K.R. Walder, P. Zimmet, J.W. MacCluer, G.R. Collier, A.H. Kissebah, J. Blangero, Genetic variation in selenoprotein S influences inflammatory response. Nat. Genet. 37, 1234–1241 (2005)
98. L.R. Santos, C. Durães, A. Mendes, H. Prazeres, I. Alvelos, C.S. Moreira, P. Canedo, C. Esteves, C. Neves, D. Carvalho, M.S. Simões, P. Soares, A polymorphism in the promoter region of Selenoprotein S gene (SEPS1) contributes to Hashimoto’s thyroiditis susceptibility. J. Clin. Endocrinol. Metab. 99, jc20133539 (2014)
99. C. Marcocci, G.J. Kahaly, G.E. Krassas, L. Bartalena, M. Prummel, M. Stahl, M.A. Altea, M. Nardi, S. Pitz, K. Boboridis, P. Sivelli, G. von Arx, M.P. Mourits, L. Baldeschi, W. Bencivelli, W. Wiersinga, European Group on Graves’ Orbitopathy. Selenium and the course of mild Graves’ orbitopathy. N. Engl. J. Med. 364, 1920–1931 (2011)
100. I. Bülow Pedersen, N. Knudsen, A. Carlé, L. Schomburg, J. Köhrle, T. Jørgensen, L.B. Rasmussen, L. Ovesen, P. Laurberg, Serum selenium is low in newly diagnosed Graves’ disease: a population-based study. Clin. Endocrinol. (Oxf) 79, 584–590 (2013)
101. A. Drutel, F. Archambeaud, P. Caron, Selenium and the thyroid gland: more good news for clinicians. Clin. Endocrinol. (Oxf) 78, 156–164 (2013). doi:10.111/cen.12066
102. T. Wertenbruch, H.S. Willenberg, C. Sagert, T.B. Nguyen, M. Bahlo, J. Feldkamp, C. Groeger, D. Hermsen, W.A. Scherbaum, M. Schott, Serum selenium levels in patients with remission and relapse of Graves’ disease. Med. Chem. 3, 281–284 (2007)
103. G.M. Lehmann, S.E. Feldon, T.J. Smith et al., Immune mechanisms in thyroid eye disease. Thyroid 18, 959–965 (2008)
104. N. Xia, S. Zhou, Y. Liang, C. Xiao, H. Shen, H. Pan, H. Deng, N. Wang, Q.Q. Li, CD4+T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves’ ophthalmopathy. Int. J. Mol. Med. 17, 911–916 (2006)
105. L. Kiremidjian-Schumacher, M. Roy, H.I. Wishe, M.W. Cohen, G. Stotzky, Selenium and immune cell functions. I. Effect on lymphocyte proliferation and production of interleukin 1 and interleukin 2. Proc. Soc. Exp. Biol. Med. 193, 136–142 (1990)
106. Z. Zhang, W. Yu, J.L. Hargrove, P. Greenspan, R.G. Dean, E.W. Taylor, D.K. Hartle, Inhibition of TNF-α induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis 161, 381–386 (2002)
107. L.H. Duntas, The evolving role of selenium in the treatment of graves’ disease and ophthalmopathy. J. Thyroid Res. (2012). doi:10.1155/2012/736161
108. Z. Huang, A.H. Rose, P.R. Hoffmann, The role of selenium in inflammation and immunity: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 16 (2012). doi:10.1089/Ars.2011.4145
109. L.B. Rasmussen, L. Schomburg, J. Köhrle, I.B. Pedersen, B. Hollenbach, A. Hög, S. Ovesen, H. Perrild, P. Laurberg, Selenium status, thyroid volume, and multiple nodule formation in a area with mild iodine deficiency. Eur. J. Endocrinol. 164, 585–590 (2011)
110. V.F. Brauer, U. Schweizer, J. Köhrle, R. Paschke, Selenium and goiter prevalence in borderline iodine sufficiency. Eur. J. Endocrinol. 155, 807–812 (2006)
111. H. Derumeaux, P. Valeix, K. Castetbon, M. Bensimon, M.C. Boutron-Ruault, J. Arnaud, S. Hercberg, Association of selenium with thyroid volume and echostructure in 35- to 60-year-old French adults. Eur. J. Endocrinol. 148, 309–315 (2003)
112. H. Xue, W. Wang, Y. Li, Z. Shan, Y. Li, X. Teng, Y. Gao, C. Fan, W. Teng, Selenium upregulates CD4 (+) CD25 (+) regulatory T cells in iodine-induced autoimmune thyroiditis model of NOD.H-2(h4) mice. Endocr. J. 57, 595–601 (2010)
113. C. Balázs, V. Kaczur, Effect of selenium on expression of HLA-DR thyrocytes. Autoimmune Dis. 37, 4635 (2012)
114. R. Krysiak, B. Okopien, The effect of levothyroxine and selenomethionine on lymphocyte and monocyte cytokine release in women with Hashimoto’s thyroiditis. J. Clin. Endocrinol. Metab. 96, 2206–2215 (2011). doi:10.1210/jc.2010-2986
115. B.A. Carlson, M.H. Yoo, R.K. Shrimali, R. Irons, V.N. Gladyshev, D.L. Hatfield, J.M. Park, Role of selenium-containing proteins in T-cell and macrophage function. Proc. Nutr. Soc. 69, 300–331 (2010)
116. R.K. Shrimali, R.D. Irons, B.A. Carlson, Y. Sano, V.N. Gladyshev, J.M. Park, D.L. Hatfield, Selenoproteins mediate T cell immunity through an antioxidant mechanism. J. Biol. Chem. 283, 20181–20185 (2008)
117. A. Dumitrescu, S. Refetoff, Inherited defects of thyroid hormone metabolism. Ann. Endocrinol. (Paris) 72, 95–98 (2011)
118. A.M. Dumitrescu, X.H. Liao, M.S. Abdullah, J. Lado-Abeal, F.A. Majed, L.C. Moeller, G. Boran, L. Schomburg, R.E. Weiss, S. Refetoff, Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat. Genet. 37, 1247–1252 (2005)
119. M.F. Azevedo, G.B. Barra, L.A. Naves, L.F. Ribeiro Velasco, P. Godoy Garcia Castro, L.C. de Castro, A.A. Amato, A. Miniard, D. Driscoll, L. Schomburg, F. de Assis Rocha Neves, Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. J. Clin. Endocrinol. Metab. 95, 4066–4071 (2010). doi:10.1210/jc.2009-2611
120. E. Shoenmakers, M. Agostini, C. Mitchell, N. Schoenmakers, L. Papp, O. Rajanayagam, R. Padidela, L. Ceron-Gutierrez, R. Döffinger, C. Provost, J. Luan, S. Montano, J. Lu, M. Castanet, N. Clemons, M. Groeneveld, P. Castets, M. Karbaschi, S. Aitken, A. Dixon, J. Williams, I. Campi, M. Blount, H. Burton, F. Muntoni, D. O’Donovan, A. Dean, A. Warren, C. Brierley, D. Baguley, P. Guicheney, R. Fitzgerald, A. Coles, H. Gaston, P. Todd, A. Holmgren, K.K. Khanna, M. Cooke, R. Semple, D. Halsall, N. Wareham, J. Schwabe, L. Grasso, P. Beck-Peccoz, A. Ogunko, M. Dattani, M. Gurnell, K. Chatterjee, Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. J. Clin. Invest. 120, 4220–4235 (2010)
121. C. Di Cosmo, N. McLellan, X.H. Liao, K.K. Khanna, R.E. Weiss, L. Papp, S. Refetoff, Clinical and molecular characterization of nine selenocysteine insertion sequence-binding protein 2 (SBP2) gene mutation (R128X). J. Clin. Endocrinol. Metab. 94, 4003–4009 (2009)
122. L. Schomburg, A.M. Dumitrescu, X.H. Liao, B. Bin-Abbas, J. Hoeflich, J. Köhrle, S. Refetoff, Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 19, 277–281 (2009)
123. J. Bleys, A. Navas-Acien, E. Guallar, Serum selenium and diabetes in U.S adults. Diabetes Care 30, 829–834 (2007)
124. M. Laclaustra, A. Navas-Acien, S. Stranges, J.M. Ordovas, E. Guallar, Serum selenium concentrations and diabetes in U.S. adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Environ. Health Perspect. 117, 1409–1413 (2009). doi:10.1289/ehp.0900704
125. S. Stranges, J.R. Marshall, R. Natarajan, R.P. Donahue, M. Trevisan, G.F. Combs, F.P. Cappuccio, A. Ceriello, M.E. Reid, Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Int. Med. 147, 217–223 (2007)
126. S.M. Lippman, E.A. Klein, P.J. Goodman, M.S. Lucia, I.M. Thompson, L.G. Ford, H.L. Parnes, L.M. Minasian, J.M. Gaziano, J.A. Hartline, J.K. Parsons, J.D. Bearden 3rd, E.D. Crawford, G.E. Goodman, J. Claudio, E. Winquist, E.D. Cook, D.D. Karp, P. Walther, M.M. Lieber, A.R. Kristal, A.K. Darke, K.B. Arnold, P.A. Ganz, R.M. Santella, D. Albanes, P.R. Taylor, J.L. Probstfield, T.J. Jagpal, J.J. Crowley, F.L. Meyskens Jr, L.H. Baker and C.A. Coltman Jr., Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 301, 39–51 (2009)
127. J. Arnaud, T.N. Akbaraly, I. Hininger, A.M. Roussel, C. Berr, Factors associated with longitudinal plasma selenium decline in the elderly: the EVA study. J. Nutr. Biochem. 18, 482–487 (2007)
128. N.T. Akbaraly, J. Arnaud, I. Favier Hininger, V. Gourlet, A.M. Roussel, C. Berr, Selenium and mortality in the elderly: results from the EVA study. Clin. Chem. 51, 2117–2123 (2005)
129. S. Mao, A. Zhang, S. Huang, Selenium supplementation and the risk of type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Endocrine (2014) Epub ahead of print
130. M.P. Rayman, G. Blundell-Pound, R. Pastor-Barriuso, E. Guallar, H. Steinbrenner, S. Stranges, A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin. PLoS One 7, e45269 (2012). doi:10.1371/journal.pone.0045269
131. J.N. Hellwege, N.D. Palmer, J.T. Ziegler, C.D. Langefeld, C. Lorenzo, J.M. Norris, T. Takamura, D.W. Bowden, Genetic variants in selenoprotein P plasma 1 gene (SEPP1) are associated with fasting insulin and first phase insulin response in Hispanics. Gene 534, 33–39 (2014)
132. B.J. Ko, S.M. Kim, K.H. Park, H.S. Park, C.S. Mantzoros, Levels of circulating selenoprotein P, fibroblast growth factor (FGF) 21 and FGF23 in relation to the metabolic syndrome in young children. Int. J. Obes. (Lond) 18 (2014). doi:10.1038/ijo.2014.45
133. H. Misu, K. Ishikura, S. Kurita, Y. Takeshita, T. Ota, Y. Saito, K. Takahashi, S. Kaneko, T. Takamura, Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes. PLoS One 7, e34952 (2012). doi:10.1371/journal.pone.0034952
134. H. Steinbrenner, Interference of selenium and selenoproteins with the insulin-regulated carbohydrate and lipid metabolism. Free Radic. Biol. Med. 65, 1538–1547 (2013). doi:10.1016/j.freeradbiomed.2013.07.016
135. C. Kornhauser, J.R. Garcia-Ramirez, K. Wrobel, E.L. Pérez-Luque, M.E. Garay-Sevilla, K. Wrobel, Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients. Prim. Care Diabetes. 2, 81–85 (2008)
136. M. Navarro-Alarcón, H. López-G de la Serrana, V. Pérez-Valero, C. López-Martínez, Serum and urine selenium concentrations as indicators of body status in patients with diabetes mellitus. Sci. Total Environ. 228, 79–88 (1999)
137. H. Steinbrenner, B. Speckmann, A. Pinto, H. Sies, High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J. Clin. Biochem. Nutr. 48, 40–45 (2011)
138. A. Pinto, D.T. Juniper, M. Sanil, L. Morgan, L. Clark, H. Sies, M.P. Rayman, H. Steinbrenner, Supranutritional selenium induces alterations in molecular targets related to energy metabolism in skeletal muscle and visceral adipose tissue of pigs. J. Inorg. Biochem. 114, 47–54 (2012). doi:10.1016/j.jinorgbio.2012.04.011
139. X. Wang, W. Zhang, H. Chen, N. Liao, Z. Wang, X. Zhang, C. Hai, High selenium impairs hepatic insulin sensitivity through opposite regulation of ROS. Toxicol. Lett. 224, 16–23 (2014). doi:10.1016/j.toxlet.2013.10.005
140. A.S. Mueller, J. Pallauf, Compendium of the antidiabetic effects of supranutritional selenate doses. In vivo and in vitro investigations with type II diabetic db/db mice. J. Nutr. Biochem. 17, 548–560 (2006)
141. C. Wang, S. Yang, N. Zhang, Y. Mu, H. Ren, Y. Wang, K. Li, Long-term supranutritional supplementation with selenate decreases hyperglycemia and promotes fatty liver degeneration by inducing hyperinsulinemia in diabetic db/db mice. PLoS One 9, e101315 (2014). doi:10.1371/journal.pone.0101315
142. C.R. Rocourt, W.H. Cheng, Selenium supranutrition: are the potential benefits of chemoprevention outweighed by the promotion of diabetes and insulin resistance? Nutrients 5, 1349–1365 (2013)
143. M.P. Rayman, S. Stranges, B.A. Griffin, R. Pastor-Barriuso, E. Guallar, Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial. Ann. Int. Med. 154, 656–665 (2011). doi:10.7326/0003-4819-154-10-201105170-00005
144. M. Laclaustra, S. Stranges, A. Navas-Acien, J.M. Ordovas, E. Guallar, Serum selenium and serum lipids in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2004. Atherosclerosis. 210, 643–648 (2010). doi:10.1016/j.atherosclerosis
145. M.P. Rayman, S. Stranges, Epidemiology of selenium and type 2 diabetes: can we make sense of it? Free Radic. Biol. Med. 65, 1557–1564 (2013)
146. M.P. Rayman, Selenium and human health. Lancet 379, 1256–1268 (2012)
147. K. Rees, L. Hartley, C. Day, N. Flowers, A. Clarke, S. Stranges, Selenium supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst. Rev. 1, CD009671 (2013). doi:10.1002/14651858.CD009671.pub2
148. L. Flohé, Selenium in mammalian spermiogenesis. Biol. Chem. 388, 987–995 (2007)
149. G.E. Olson, V.P. Winfrey, S.K. Nagdas, K.E. Hill, R.F. Burk, Apolipoprotein E receptor-2 (ApoER2) mediates selenium uptake from selenoprotein P by the mouse testis. J. Biol. Chem. 282, 12290–12297 (2007)
150. D. Behne, H. Weiler, A. Kyriakopoulos, Effects of selenium deficiency on testicular morphology and function in rats. J. Reprod. Fertil. 106, 291–297 (1996)
151. N.B. Oldereid, Y. Thomassen, K. Purvis, Selenium in human male reproductive organs. Hum. Reprod. 13, 2172–2176 (1998)
152. C. Foresta, L. Flohe, A. Garolla, A. Roveri, F. Ursini, M. Maiorino, Male fertility is linked to the selenoprotein phospholipid hydroperoxide glutathione peroxidase. Biol. Reprod. 67, 967–971 (2002)
153. K. Nayernia, M. Diaconu, G. Aumüller, G. Wennemuth, I. Schwandt, K. Kleene, H. Kuehn, W. Engel, Phospholipid hydroperoxide glutathione peroxidase: expression pattern during testicular development in mouse and evolutionary conservation in spermatozoa. Mol. Reprod. Dev. 67, 458–464 (2004)
154. F. Ursini, S. Heim, M. Kiess, M. Maiorino, A. Roveri, J. Wissing, L. Flohe, Dual function of the selenoprotein PHGPX during sperm maturation. Science 285, 1393–1396 (1999)
155. M. Maiorino, J.B. Wissing, R. Brigelius-Flohé, F. Calabrese, A. Roveri, P. Steinert, F. Ursini, L. Flohé, Testosterone mediates expression of the selenoprotein PHGPX by induction of spermatogenesis and not by direct transcriptional gene activation. FASEB J. 12, 1359–1370 (1998)
156. M. Michaelis, O. Gralla, T. Behrends, M. Scharpf, T. Endermann, E. Rijntjes, N. Pietschmann, B. Hollenbach, L. Schomburg, Selenoprotein P in seminal fluid is a novel biomarker of sperm quality. Biochem. Biophys. Res. Commun. 443, 905–910 (2014). doi:10.1016/j.bbrc.2013.12.06
157. M. Mirone, E. Giannetta, A.M. Isidori, Selenium and reproductive function. A systematic review. J. Endocrinol. Invest. 36, 28–36 (2013)
158. R. Scott, A. MacPherson, R.W. Yates, B. Hussain, J. Dixon, The effect of oral selenium supplementation on human sperm motility. Br. J. Urol. 82, 76–80 (1998)
159. S. Türk, R. Mändar, R. Mahlapuu, A. Viitak, M. Punab, T. Kullisaar, Male infertility: decreased levels of selenium, zinc and antioxidants. J. Trace Elem. Med Biol. 28, 179–185 (2014). doi:10.1016/j.jtemb.2013.12.005
160. A. Duncan, D. Talwar, D.C. McMillan, F. Stefanowicz, D.S. O’Reilly, Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am. J. Clin. Nutr. 95, 64–71 (2012). doi:10.3945/ajcn.111.023812
161. M. Harthill, Micronutrient selenium deficiency influences evolution of some viral infectious diseases. Biol. Trace Elem. Res. 143, 1325–1336 (2011). doi:10.1007/s12011-011-8977-1
162. O.A. Levander, M.A. Beck, Selenium and viral virulence. Brit. Med. Bull. 55, 5528–5533 (1999)
163. M.A. Beck, Q. Shi, V.C. Morris, O.A. Levander, Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates. Nat. Med. 1, 433–436 (1995)
164. M.A. Beck, R.S. Esworthy, Y.S. Ho, F.F. Chu, Glutathione peroxidase protects mice from viral-induced myocarditis. FASEB J. 12, 1143–1149 (1998)
165. L. Yu, L. Sun, Y. Nan, L.Y. Zhu, Protection from H1N1 influenza virus infections in mice by supplementation with selenium: a comparison with selenium-deficient mice. Biol. Trace Elem. Res. 141, 254–261 (2011)
166. S. Verma, Y. Molina, Y.Y. Lo, B. Cropp, C. Nakano, R. Yanagihara, V.R. Nerurkar, In vitro effects of selenium deficiency on West Nile virus replication and cytopathogenicity. Virol. J. 5, 66 (2008). doi:10.1186/1743-422X-5-66
167. I. Jaspers, W. Zhang, L.E. Brighton, J.L. Carson, M. Styblo, M.A. Beck, Selenium deficiency alters epithelial cell morphology and responses to influenza. Free Radic. Biol. Med. 42, 1826–1837 (2007)
168. S.J. Allsup, A. Shenkin, M.A. Gosney, S. Taylor, W. Taylor, M. Hammond, M.C. Zambon, Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized, controlled trial. J. Am. Geriatr. Soc. 52, 20–24 (2004)
169. C.S. Broome, F. McArdle, J.A. Kyle, F. Andrews, N.M. Lowe, C.A. Hart, J.R. Arthur, M.J. Jackson, An increase in selenium intake improves immune function and poliovirus handling in adults with marginal selenium status. Am. J. Clin. Nutr. 80, 154–162 (2004)
170. C.A. Stone, K. Kawai, R. Kupka, W.W. Fawzi, Role of selenium in HIV infection. Nutr. Rev. 68, 671–681 (2010). doi:10.1111/j.1753-4887.2010.00337.x
171. M.C. Rousseau, C. Molines, J. Moreau, J. Delmont, Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients. Ann. Nutr. Metab. 44, 212–216 (2000)
172. G. Shor-Posner, M.J. Miguez, L.M. Pineda, A. Rodriguez, P. Ruiz, G. Castillo, X. Burbano, R. Lecusay, M. Baum, Impact of selenium status on the pathogenesis of mycobacterial disease in HIV-1-infected drug users during the era of highly active antiretroviral therapy. J. Acquir. Immune Defic. Syndr. 29, 169–173 (2002)
173. X. Forceville, D. Vitoux, Selenium systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit. Care Med. 26, 1536–1544 (1998)
174. C. Sanmartin, D. Plano, M. Font, J.A. Palop, Selenium and clinical trials: new therapeutic evidence for multiple diseases. Curr. Med. Chem. 18, 4635–4650 (2011)
175. J. Bleys, A. Navas-Acien, E. Guallar, Serum selenium levels and all-cause, cancer and cardiovascular mortality among US adults. Arch. Int. Med. 168, 404–410 (2008)
176. W. Alhazzani, J. Jacobi, A. Sindi, C. Hartog, K. Reinhart, S. Kokkoris, H. Gerlach, P. Andrews, T. Drabek, W. Manzanares, D.J. Cook, R.Z. Jaeschke, The effect of selenium therapy on mortality in patients with sepsis syndrome: a systematic review and meta-analysis of randomized controlled trials. Crit. Care Med. 41, 1555–1564 (2013)
177. T.S. Huang, Y.C. Shyu, H.Y. Chen, L.M. Lin, C.Y. Lo, S.S. Yuan, P.J. Chen, Effect of parenteral selenium supplementation in critically ill patients: a systematic review and meta-analysis. PLoS One 8, e54431 (2013). doi:10.1371/journal.pone.0054431
178. F. Landucci, P. Mancinelli, A.R. De Gaudio, G. Virgili, Selenium supplementation in critically ill patients: a systematic review and meta-analysis. J. Crit. Care 29, 150–156 (2014). doi:10.1016/j.jcrc.2013.08.017
179. Z. Kong, F. Wang, S. Ji, X. Deng, Z. Xia, Selenium supplementation for sepsis: a meta-analysis of randomized controlled trials. Am. J. Emerg. Med. 31, 1170–1175 (2013). doi:10.1016/j.ajem.2013.04.020
180. G. Hardy, I. Hardy, W. Manzanares, Selenium supplementation in the critically ill. Nutr. Clin. Pract. 27, 21–33 (2012). doi:10.1177/0884533611434116
181. H.A. Meyer, T. Endermann, C. Stephan, M. Stoedter, T. Behrends, I. Wolff, K. Jung, L. Schomburg, Selenoprotein P status correlates to cancer-specific mortality in renal cancer patients. PLoS One 7, e46644 (2012). doi:10.1371/journal.pone.0046644